These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1362820)

  • 41. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
    Ippoliti C; Przepiorka D; Giralt S; Andersson BS; Wallerstein RO; Gutterman J; Deisseroth AB; Champlin RE
    Bone Marrow Transplant; 1993 Jan; 11(1):55-9. PubMed ID: 8094309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
    Gorin NC; Coiffier B; Hayat M; Philip T; Vernant JP; Hervé P; Colombat P; Boivin P; Slavin S; Eugène-Jolchine I
    Bone Marrow Transplant; 1991; 7 Suppl 2():82. PubMed ID: 1878733
    [No Abstract]   [Full Text] [Related]  

  • 44. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications.
    Hill AD; Naama HA; Calvano SE; Daly JM
    J Leukoc Biol; 1995 Dec; 58(6):634-42. PubMed ID: 7499960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral blood stem cell transplantation: historical perspective, current status, and prospects for the future.
    Inwards D; Kessinger A
    Transfus Med Rev; 1992 Jul; 6(3):183-90. PubMed ID: 1353998
    [No Abstract]   [Full Text] [Related]  

  • 47. [Colony stimulating factor (CSF)--various aspects of its therapeutic use].
    Zduńczyk A
    Pol Arch Med Wewn; 1990 Jul; 84(1):44-53. PubMed ID: 2251218
    [No Abstract]   [Full Text] [Related]  

  • 48. Biological and clinical aspects of hematopoietic stem cells.
    Spangrude GJ
    Annu Rev Med; 1994; 45():93-104. PubMed ID: 7515222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The process of hematological reconstitution after human bone marrow transplantation].
    Tani K; Asano S
    Nihon Rinsho; 1990 Sep; 48(9):1954-64. PubMed ID: 2232198
    [No Abstract]   [Full Text] [Related]  

  • 50. Rapid recovery of hematopoiesis in patients given high-dose chemotherapy followed by infusion of refrigerated unprocessed autologous bone marrow and peripheral blood.
    Aggarwal S; Singh B; Sood SK; Kumra VP; Byotra SP; Sachar VP; Saran RK
    Transplant Proc; 2000 Nov; 32(7):2460-1. PubMed ID: 11120244
    [No Abstract]   [Full Text] [Related]  

  • 51. Hematopoietic effects and clinical application of granulopoietic growth factors.
    Höglund M
    Ups J Med Sci; 1996; 101(2):121-48. PubMed ID: 8897704
    [No Abstract]   [Full Text] [Related]  

  • 52. Observations on the effects of hematopoietic colony-stimulating factors on the clinical course of bone marrow transplantation.
    Peters WP
    Recent Results Cancer Res; 1993; 132():97-101. PubMed ID: 7505472
    [No Abstract]   [Full Text] [Related]  

  • 53. The potential for the use of colony-stimulating factors in autologous bone marrow transplantation.
    Peters WP
    Recent Results Cancer Res; 1991; 121():182-8. PubMed ID: 1713337
    [No Abstract]   [Full Text] [Related]  

  • 54. Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application.
    Neumanaitis J
    Transfusion; 1993 Jan; 33(1):70-83. PubMed ID: 8424270
    [No Abstract]   [Full Text] [Related]  

  • 55. Granulocyte-macrophage colony-stimulating factor.
    Devereux S; Linch DC
    Biotherapy; 1990; 2(4):305-13. PubMed ID: 2148492
    [No Abstract]   [Full Text] [Related]  

  • 56. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.
    Armitage JO
    Blood; 1998 Dec; 92(12):4491-508. PubMed ID: 9845514
    [No Abstract]   [Full Text] [Related]  

  • 57. The colony-stimulating factors.
    Henderson G
    Aust Nurses J; 1991 Mar; 20(7):27-8. PubMed ID: 2049007
    [No Abstract]   [Full Text] [Related]  

  • 58. The hematopoietic cytokines: an overview.
    Murphy MJ
    Toxicol Pathol; 1993; 21(2):229-30. PubMed ID: 7692584
    [No Abstract]   [Full Text] [Related]  

  • 59. [Progress on the diagnosis and therapy of anemia--cell differentiation of erythroblasts and hematopoiesis factors].
    Bessho M
    Nihon Naika Gakkai Zasshi; 1999 Jun; 88(6):962-7. PubMed ID: 10465935
    [No Abstract]   [Full Text] [Related]  

  • 60. Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it?
    Moore MA
    Blood; 1992 Jul; 80(1):3-7. PubMed ID: 1377052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.